dihexa safety concerns hgf c-met cancer risk Frontiers c-Met Signaling as a Therapeutic
c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications PMC Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link Targeting the HGF c MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis British Journal of Cancer Developing c MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




